Ownership history in Qube Research & Technologies Ltd · 10 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in ABEONA THERAPEUTICS INC (ABEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 225,868 | +192,075 | +568.4% | 0.00% | $1.2M | $5.28 |
| 2025 Q2 | REDUCED | 33,793 | -66,348 | -66.3% | 0.00% | $192K | $5.68 |
| 2025 Q1 | REDUCED | 100,141 | -61,739 | -38.1% | 0.00% | $477K | $4.76 |
| 2024 Q4 | ADDED | 161,880 | +101,199 | +166.8% | 0.00% | $902K | $5.57 |
| 2024 Q3 | ADDED | 60,681 | +41,665 | +219.1% | 0.00% | $384K | $6.32 |
| 2024 Q2 | REDUCED | 19,016 | -53,782 | -73.9% | 0.00% | $81K | $4.24 |
| 2024 Q1 | ADDED | 72,798 | +71,013 | +3978.3% | 0.00% | $528K | $7.25 |
| 2023 Q4 | REDUCED | 1,785 | -20,787 | -92.1% | 0.00% | $9K | $5.01 |
| 2021 Q2 | REDUCED | 22,572 | -11,374 | -33.5% | 0.00% | $35K | $39.00 |
| 2020 Q2 | INITIATED | 33,946 | — | — | 0.00% | $99K | $73.00 |
As of 2025 Q4 — sorted by position size